

SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.


Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.

Workers handle Covid-19 vaccines at a distribution center in Chandigarh, India on May 4, 2021. (Photo: Ravi Kumar/Hindustan Times via Getty Images)
As the United States on Wednesday broke with other wealthy nations to support waiving intellectual property protections for Covid-19 vaccines, global health leaders applauded President Joe Biden's administration, while healthcare advocates shifted the focus of their pressure to other countries whose leaders are either undecided or opposed to the move.
"If the U.S. truly wants to end this pandemic, it must also share its surplus vaccines doses with COVAXnow and fill the access gap until additional manufactures are able to scale up production."
--Avril Benoit, MSF
World Health Organization (WHO) Director-General Dr. Tedros Adhanom Ghebreyesus, a vocal advocate of the waiver, led the worldwide praise of the American policy shift.
"This is a monumental moment in the fight against Covid-19," Tedros said in a statement. "The commitment by... Biden and Ambassador Katherine Tai, the U.S. trade representative, to support the waiver of IP protections on vaccines is a powerful example of American leadership to address global health challenges."
"I commend the United States on its historic decision for vaccine equity and prioritizing the well-being of all people everywhere at a critical time," he added. "Now let's all move together swiftly, in solidarity, building on the ingenuity and commitment of scientists who produced lifesaving Covid-19 vaccines."
Avril Benoit, executive director of the U.S. division of the international medical charity Medecins Sans Frontieres (MSF, or Doctors Without Borders), also welcomed news of the Biden administration's decision--while pushing the United States to do more.
"MSF applauds the U.S. government's bold decision to support the waiving of intellectual property on Covid-19 vaccines during this time of unprecedented global need," Benoit said in a statement. "It is crucial that this waiver not just apply to preventative vaccines, but it should also cover other medical tools for Covid-19, including treatments for people who fall ill and diagnostics to help curb the spread, as originally proposed seven months ago."
"If the U.S. truly wants to end this pandemic, it must also share its surplus vaccines doses with COVAX now and fill the access gap until additional manufactures are able to scale up production," Benoit added. "The U.S. must also demand that pharma companies that received significant amounts of U.S. taxpayer funding to create these vaccines share the technology and know-how with other capable manufacturers to protect more people worldwide."
Benoit called on other wealthy members of the World Trade Organization to follow the U.S. lead.
"Countries that continue to oppose the WTO waiver--such as European Union countries, the United Kingdom, Switzerland, Canada, Australia, Norway, Japan, and Brazil--must now take action, too and decide to put people's health before pharmaceutical profits and waive IP on all Covid-19 medical tools, including vaccines," she wrote.
Healthcare advocates turned their attention those countries after the Biden administration's announcement, with many eyes on the U.S.' neighbor to the north. Some of the admonition of Ottawa was deadly serious:
Canada needs to immediately drop its opposition to a WTO patent waiver on vaccines. Now the US has reversed position, Canada has no reason to hold out. There's no big domestic industry to protect, and if the US can do it......
-- Lauren Dobson-Hughes (@ldobsonhughes) May 5, 2021
Other criticism oozed derision and disdain:
Meanwhile, the world registered more than 800,000 new Covid-19 cases--more than 300,000 of them in India--and nearly 14,000 new deaths on Tuesday, according to the Johns Hopkins Coronavirus Resource Center.
Dear Common Dreams reader, The U.S. is on a fast track to authoritarianism like nothing I've ever seen. Meanwhile, corporate news outlets are utterly capitulating to Trump, twisting their coverage to avoid drawing his ire while lining up to stuff cash in his pockets. That's why I believe that Common Dreams is doing the best and most consequential reporting that we've ever done. Our small but mighty team is a progressive reporting powerhouse, covering the news every day that the corporate media never will. Our mission has always been simple: To inform. To inspire. And to ignite change for the common good. Now here's the key piece that I want all our readers to understand: None of this would be possible without your financial support. That's not just some fundraising cliche. It's the absolute and literal truth. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. Will you donate now to help power the nonprofit, independent reporting of Common Dreams? Thank you for being a vital member of our community. Together, we can keep independent journalism alive when it’s needed most. - Craig Brown, Co-founder |
As the United States on Wednesday broke with other wealthy nations to support waiving intellectual property protections for Covid-19 vaccines, global health leaders applauded President Joe Biden's administration, while healthcare advocates shifted the focus of their pressure to other countries whose leaders are either undecided or opposed to the move.
"If the U.S. truly wants to end this pandemic, it must also share its surplus vaccines doses with COVAXnow and fill the access gap until additional manufactures are able to scale up production."
--Avril Benoit, MSF
World Health Organization (WHO) Director-General Dr. Tedros Adhanom Ghebreyesus, a vocal advocate of the waiver, led the worldwide praise of the American policy shift.
"This is a monumental moment in the fight against Covid-19," Tedros said in a statement. "The commitment by... Biden and Ambassador Katherine Tai, the U.S. trade representative, to support the waiver of IP protections on vaccines is a powerful example of American leadership to address global health challenges."
"I commend the United States on its historic decision for vaccine equity and prioritizing the well-being of all people everywhere at a critical time," he added. "Now let's all move together swiftly, in solidarity, building on the ingenuity and commitment of scientists who produced lifesaving Covid-19 vaccines."
Avril Benoit, executive director of the U.S. division of the international medical charity Medecins Sans Frontieres (MSF, or Doctors Without Borders), also welcomed news of the Biden administration's decision--while pushing the United States to do more.
"MSF applauds the U.S. government's bold decision to support the waiving of intellectual property on Covid-19 vaccines during this time of unprecedented global need," Benoit said in a statement. "It is crucial that this waiver not just apply to preventative vaccines, but it should also cover other medical tools for Covid-19, including treatments for people who fall ill and diagnostics to help curb the spread, as originally proposed seven months ago."
"If the U.S. truly wants to end this pandemic, it must also share its surplus vaccines doses with COVAX now and fill the access gap until additional manufactures are able to scale up production," Benoit added. "The U.S. must also demand that pharma companies that received significant amounts of U.S. taxpayer funding to create these vaccines share the technology and know-how with other capable manufacturers to protect more people worldwide."
Benoit called on other wealthy members of the World Trade Organization to follow the U.S. lead.
"Countries that continue to oppose the WTO waiver--such as European Union countries, the United Kingdom, Switzerland, Canada, Australia, Norway, Japan, and Brazil--must now take action, too and decide to put people's health before pharmaceutical profits and waive IP on all Covid-19 medical tools, including vaccines," she wrote.
Healthcare advocates turned their attention those countries after the Biden administration's announcement, with many eyes on the U.S.' neighbor to the north. Some of the admonition of Ottawa was deadly serious:
Canada needs to immediately drop its opposition to a WTO patent waiver on vaccines. Now the US has reversed position, Canada has no reason to hold out. There's no big domestic industry to protect, and if the US can do it......
-- Lauren Dobson-Hughes (@ldobsonhughes) May 5, 2021
Other criticism oozed derision and disdain:
Meanwhile, the world registered more than 800,000 new Covid-19 cases--more than 300,000 of them in India--and nearly 14,000 new deaths on Tuesday, according to the Johns Hopkins Coronavirus Resource Center.
As the United States on Wednesday broke with other wealthy nations to support waiving intellectual property protections for Covid-19 vaccines, global health leaders applauded President Joe Biden's administration, while healthcare advocates shifted the focus of their pressure to other countries whose leaders are either undecided or opposed to the move.
"If the U.S. truly wants to end this pandemic, it must also share its surplus vaccines doses with COVAXnow and fill the access gap until additional manufactures are able to scale up production."
--Avril Benoit, MSF
World Health Organization (WHO) Director-General Dr. Tedros Adhanom Ghebreyesus, a vocal advocate of the waiver, led the worldwide praise of the American policy shift.
"This is a monumental moment in the fight against Covid-19," Tedros said in a statement. "The commitment by... Biden and Ambassador Katherine Tai, the U.S. trade representative, to support the waiver of IP protections on vaccines is a powerful example of American leadership to address global health challenges."
"I commend the United States on its historic decision for vaccine equity and prioritizing the well-being of all people everywhere at a critical time," he added. "Now let's all move together swiftly, in solidarity, building on the ingenuity and commitment of scientists who produced lifesaving Covid-19 vaccines."
Avril Benoit, executive director of the U.S. division of the international medical charity Medecins Sans Frontieres (MSF, or Doctors Without Borders), also welcomed news of the Biden administration's decision--while pushing the United States to do more.
"MSF applauds the U.S. government's bold decision to support the waiving of intellectual property on Covid-19 vaccines during this time of unprecedented global need," Benoit said in a statement. "It is crucial that this waiver not just apply to preventative vaccines, but it should also cover other medical tools for Covid-19, including treatments for people who fall ill and diagnostics to help curb the spread, as originally proposed seven months ago."
"If the U.S. truly wants to end this pandemic, it must also share its surplus vaccines doses with COVAX now and fill the access gap until additional manufactures are able to scale up production," Benoit added. "The U.S. must also demand that pharma companies that received significant amounts of U.S. taxpayer funding to create these vaccines share the technology and know-how with other capable manufacturers to protect more people worldwide."
Benoit called on other wealthy members of the World Trade Organization to follow the U.S. lead.
"Countries that continue to oppose the WTO waiver--such as European Union countries, the United Kingdom, Switzerland, Canada, Australia, Norway, Japan, and Brazil--must now take action, too and decide to put people's health before pharmaceutical profits and waive IP on all Covid-19 medical tools, including vaccines," she wrote.
Healthcare advocates turned their attention those countries after the Biden administration's announcement, with many eyes on the U.S.' neighbor to the north. Some of the admonition of Ottawa was deadly serious:
Canada needs to immediately drop its opposition to a WTO patent waiver on vaccines. Now the US has reversed position, Canada has no reason to hold out. There's no big domestic industry to protect, and if the US can do it......
-- Lauren Dobson-Hughes (@ldobsonhughes) May 5, 2021
Other criticism oozed derision and disdain:
Meanwhile, the world registered more than 800,000 new Covid-19 cases--more than 300,000 of them in India--and nearly 14,000 new deaths on Tuesday, according to the Johns Hopkins Coronavirus Resource Center.